Orange-red birefringence of gold particles.
Keen
C E
CE
Brady
K
K
Levison
D A
DA
D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001718:Birefringence; D006801:Humans; D050607:Organogold Compounds
D018501:Antirheumatic Agents; D050607:Organogold Compounds